Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd (SHA:603227)
China · Delayed Price · Currency is CNY 10.10
+0.22 (2.23%)
Apr 1, 2026, 1:35 PM CST
SHA:603227 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 5,498 | 6,061 | 6,979 | 6,851 | 5,517 |
Other Revenue | 65.74 | 40.28 | 41.6 | 51.56 | 51.1 |
| 5,564 | 6,101 | 7,021 | 6,903 | 5,568 | |
Revenue Growth (YoY) | -8.81% | -13.10% | 1.71% | 23.96% | 169.38% |
Cost of Revenue | 4,326 | 4,701 | 5,391 | 4,897 | 3,822 |
Gross Profit | 1,237 | 1,401 | 1,630 | 2,006 | 1,747 |
Selling, General & Admin | 416.19 | 426.64 | 390.92 | 378.45 | 338.77 |
Research & Development | 83.17 | 17.78 | 29.42 | 46.46 | 26.69 |
Other Operating Expenses | 40.65 | 35.1 | 52.69 | 41.71 | 45.96 |
Operating Expenses | 581.49 | 487.73 | 487.01 | 479.41 | 425.29 |
Operating Income | 655.9 | 912.82 | 1,143 | 1,526 | 1,321 |
Interest Expense | -13.86 | -24.36 | -43.95 | -55.7 | -53.61 |
Interest & Investment Income | 27.08 | 35.66 | 34.28 | 32.02 | 21.27 |
Currency Exchange Gain (Loss) | 0.66 | 0.74 | 3.27 | -3.57 | 0.19 |
Other Non Operating Income (Expenses) | -3.72 | -9.88 | -4.78 | -15.74 | -20.83 |
EBT Excluding Unusual Items | 666.06 | 914.97 | 1,132 | 1,483 | 1,268 |
Impairment of Goodwill | - | - | - | - | -5.45 |
Gain (Loss) on Sale of Investments | - | - | - | 0.08 | 0.09 |
Gain (Loss) on Sale of Assets | 0.04 | 2.33 | -1.21 | -14.59 | -1.24 |
Asset Writedown | -2.18 | -8.71 | -8.91 | -19.24 | -49.7 |
Legal Settlements | - | - | - | - | -0.91 |
Other Unusual Items | 22.42 | 23.21 | 43.91 | 36.27 | 30.13 |
Pretax Income | 686.34 | 931.8 | 1,166 | 1,486 | 1,241 |
Income Tax Expense | 106.69 | 176.17 | 214.58 | 227.99 | 199.65 |
Earnings From Continuing Operations | 579.65 | 755.63 | 951.26 | 1,258 | 1,042 |
Minority Interest in Earnings | -75.98 | -87.2 | -97.73 | -592.11 | -598.65 |
Net Income | 503.67 | 668.43 | 853.53 | 665.83 | 443.11 |
Net Income to Common | 503.67 | 668.43 | 853.53 | 665.83 | 443.11 |
Net Income Growth | -24.65% | -21.69% | 28.19% | 50.26% | 312.22% |
Shares Outstanding (Basic) | 1,072 | 1,071 | 1,046 | 822 | 816 |
Shares Outstanding (Diluted) | 1,072 | 1,071 | 1,046 | 822 | 816 |
Shares Change (YoY) | 0.04% | 2.41% | 27.25% | 0.73% | 23.74% |
EPS (Basic) | 0.47 | 0.62 | 0.82 | 0.81 | 0.54 |
EPS (Diluted) | 0.47 | 0.62 | 0.82 | 0.81 | 0.54 |
EPS Growth | -24.68% | -23.53% | 0.74% | 49.17% | 233.13% |
Free Cash Flow | 249.98 | 583.19 | 903.28 | 953.76 | 856.37 |
Free Cash Flow Per Share | 0.23 | 0.54 | 0.86 | 1.16 | 1.05 |
Dividend Per Share | 0.150 | 0.200 | 0.250 | 0.150 | 0.070 |
Dividend Growth | -25.00% | -20.00% | 66.67% | 114.29% | 40.00% |
Gross Margin | 22.24% | 22.96% | 23.22% | 29.06% | 31.37% |
Operating Margin | 11.79% | 14.96% | 16.28% | 22.11% | 23.73% |
Profit Margin | 9.05% | 10.96% | 12.16% | 9.65% | 7.96% |
Free Cash Flow Margin | 4.49% | 9.56% | 12.87% | 13.82% | 15.38% |
EBITDA | 1,041 | 1,290 | 1,489 | 1,887 | 1,673 |
EBITDA Margin | 18.71% | 21.15% | 21.21% | 27.34% | 30.05% |
D&A For EBITDA | 384.93 | 377.38 | 346.04 | 360.76 | 351.65 |
EBIT | 655.9 | 912.82 | 1,143 | 1,526 | 1,321 |
EBIT Margin | 11.79% | 14.96% | 16.28% | 22.11% | 23.73% |
Effective Tax Rate | 15.54% | 18.91% | 18.40% | 15.34% | 16.08% |
Revenue as Reported | 5,564 | 6,101 | - | 6,903 | 5,568 |
Advertising Expenses | 2.05 | 1.67 | 0.96 | 0.79 | 2.65 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.